Skip to main content
Harold Dauerman, MD, Cardiology, Burlington, VT

HaroldLeeDauermanMD

Cardiology Burlington, VT

Interventional Cardiology

Professor, Medicine, University of Vermont College of Medicine

Dr. Dauerman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Dauerman's full profile

Already have an account?

  • Office

    111 Colchester Ave
    Mcclure 1 Cardiology Fletcher Allen Health Care
    Burlington, VT 05401
    Phone+1 802-847-3602

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1994 - 1998
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1991 - 1994
  • Harvard Medical School
    Harvard Medical SchoolClass of 1991

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2003 - 2026
  • VT State Medical License
    VT State Medical License 2001 - 2026
  • MA State Medical License
    MA State Medical License 1993 - 2017
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • International Trends in Coronary Intervention A Bridge over Rising Coronary Waters  
    Harold Dauerman, MD, JACC: Cardiovascular Imaging
  • The Unbearable Thrombus of COVID-19 Primary PCI, Thrombus, and COVID-19  
    Harold Dauerman, MD, JACC: Cardiovascular Imaging
  • Original Research Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Low-Gradient Aortic Stenosis  
    Harold L Dauerman, Jon R Resar, Steven J Yakubov, P Michael Grossman, Stanley J Chetcuti, G Michael Deeb, Jeffrey J Popma, Jae K Oh, ScienceDirect

Lectures

  • TAVR Durability and Outcomes in Patients With Failed Surgical BioprosthesesThree-Year Results From the CoreValve US Expanded Use Study - 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Authored Content

  • The Unbearable Thrombus of COVID-19 Primary PCI, Thrombus, and COVID-19September 2020

Press Mentions

  • TAVR Now Used in Almost 50% of Younger Severe Aortic Stenosis Patients
    TAVR Now Used in Almost 50% of Younger Severe Aortic Stenosis PatientsSeptember 19th, 2022
  • TAVI Sees Rapid Growth for Severe AS Across the Age Spectrum in the US
    TAVI Sees Rapid Growth for Severe AS Across the Age Spectrum in the USSeptember 17th, 2022
  • TAVR Now Used in Nearly 50% of Younger Severe AS Patients
    TAVR Now Used in Nearly 50% of Younger Severe AS PatientsSeptember 16th, 2022
  • Join now to see all

Professional Memberships